Skip to main content

POTASSIUM CITRATE

NDC 72865-193 · XLCare Pharmaceuticals, Inc.

Generic namePotassium Citrate
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
Active ingredient(s)POTASSIUM CITRATE
Strength15 meq/1
Pharmacologic classAcidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]
Marketing categoryANDA

Packages

72865-193-01 — 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72865-193-01)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

68999-435 — Potassium Citrate and Citric Acid, 68999-438 — Tricitrates, 70518-3160 — Potassium Citrate, 70518-4477 — Potassium Citrate, 71335-1706 — POTASSIUM CITRATE, 71335-1967 — Potassium Citrate, 71335-2871 — POTASSIUM CITRATE, 71335-2897 — Potassium Citrate, 72162-1758 — Potassium Citrate, 72162-1759 — Potassium Citrate, 72162-2120 — Potassium Citrate, 72162-2121 — Potassium Citrate, 72162-2122 — Potassium Citrate, 72162-2476 — POTASSIUM CITRATE, 72162-2477 — POTASSIUM CITRATE, 72162-2478 — POTASSIUM CITRATE, 72865-191 — Potassium Citrate, 72865-192 — Potassium Citrate, 83778-002 — Teeth Whitening Kit, 83778-012 — TeethWhitening Kit, +44 more

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels